Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

FDA-Industry Relations Faulted As 'Revolving Door' In BMJ Report

Executive Summary

Academic authors say that more than half of FDA medical reviewers leave to either work or consult to industry; experts chime in with mixed reactions to the findings.


Related Content

Insider Trading By Ex-FDA Official Puts Spotlight On Current Agency Practices
Califf Lowering FDA Drawbridge To Work With External Expertise
Califf Supports Combo Products Pathway At Confirmation Hearing
FDA Searches Small Industry Candidate Pool To Fill Executive Vacancies
CDER Advisory Panel Vacancies Remain High As Overall FDA Rates Improve


Related Companies